Company profile: IntegriChain
1.1 - Company Overview
Company description
- Provider of revenue optimization technology and insights for the pharma industry, combining data management, enterprise applications, consulting, and outsourcing to connect commercial execution to net revenue. Offerings include the ICyte data and analytics platform, life science consulting, contracts and pricing, gross-to-net, channel insights, and patient access services.
Products and services
- ICyte Platform: An enterprise-grade data, analytics, and business process platform engineered for pharmaceutical commercialization and market access, aligning analytics with commercialization and access activities
- Gross-to-Net: An analytics-driven product that projects and helps understand the true net price of pharmaceutical products for Pharma, enabling accurate evaluation of net pricing
- Contracts & Pricing: A compliance-focused service that optimizes pricing strategies and ensures adherence to commercial obligations, governing Pharma contracts and pricing practices to support commercialization and market access
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to IntegriChain
Agility Clinical
HQ: United States
Website
- Description: Provider of consulting and contract research services for virtual and small biopharma and device companies with lean infrastructure, offering expertise to support programs—particularly in orphan drug development—and help them move forward.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Agility Clinical company profile →
Medical Research Network
HQ: United States
Website
- Description: Provider of clinical research studies on mental health, neurological, and chronic pain disorders.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Medical Research Network company profile →
Kentucky Clinical Trials Laboratory
HQ: United States
Website
- Description: Provider of pharmaceutical and diagnostic clinical trials, specimen collection, and medical studies to support research, development, and regulatory transition of novel products in medicine for business organizations.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Kentucky Clinical Trials Laboratory company profile →
Colorcon
HQ: United States
Website
- Description: Provider of specialty excipients, film coatings (immediate, enteric, sustained release), and functional packaging for solid oral dosage forms in pharmaceutical, nutritional, and animal health markets. Provides formulation support to enhance adherence, reduce medication errors, and add brand value. Products include Opadry, Acryl-EZE, Surelease, Starch 1500, METHOCEL, and StarTab, plus label-friendly solutions for dietary supplements.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Colorcon company profile →
Pyxant Labs
HQ: United States
Website
- Description: Provider of GLP bioanalytical chemistry services as a contract research laboratory for life sciences clients, offering bioanalytical method development (validation and optimization), analytical and bioanalytical support for ADME and PK/PD studies, and spatial bioanalysis and spatial biology solutions from discovery through clinical development and NDA approval.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Pyxant Labs company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for IntegriChain
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to IntegriChain
2.2 - Growth funds investing in similar companies to IntegriChain
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for IntegriChain
4.2 - Public trading comparable groups for IntegriChain
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →